<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Arch Dis Child</journal-id>
      <journal-id journal-id-type="iso-abbrev">Arch. Dis. Child</journal-id>
      <journal-id journal-id-type="hwp">archdischild</journal-id>
      <journal-id journal-id-type="publisher-id">adc</journal-id>
      <journal-title-group>
        <journal-title>Archives of Disease in Childhood</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0003-9888</issn>
      <issn pub-type="epub">1468-2044</issn>
      <publisher>
        <publisher-name>BMJ Publishing Group</publisher-name>
        <publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24273099</article-id>
      <article-id pub-id-type="pmc">4518659</article-id>
      <article-id pub-id-type="publisher-id">archdischild-2013-305511</article-id>
      <article-id pub-id-type="doi">10.1136/archdischild-2013-305511</article-id>
      <article-categories>
        <subj-group subj-group-type="hwp-journal-coll">
          <subject>1506</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>PostScript</subject>
        </subj-group>
        <series-title>Letters</series-title>
      </article-categories>
      <title-group>
        <article-title>Respiratory PCR detects influenza after intranasal live-attenuated influenza vaccination</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Lumley</surname>
            <given-names>S</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Atkinson</surname>
            <given-names>C</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Haque</surname>
            <given-names>T</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff><addr-line>UCL Department of Virology</addr-line>, <institution>Royal Free London NHS Foundation Trust</institution>, <addr-line>London</addr-line>, <country>UK</country></aff>
      <author-notes>
        <corresp><label>Correspondence to</label> Dr S Lumley, UCL Department of Virology, Royal Free London NHS Foundation Trust, Pond Street, London NW3 2QG, UK; <email>sheila.lumley@nhs.net</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>22</day>
        <month>11</month>
        <year>2013</year>
      </pub-date>
      <volume>99</volume>
      <issue>3</issue>
      <fpage>301</fpage>
      <lpage>301</lpage>
      <history>
        <date date-type="accepted">
          <day>30</day>
          <month>10</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license license-type="open-access">
          <license-p>This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link></license-p>
        </license>
      </permissions>
      <self-uri xlink:title="pdf" xlink:type="simple" xlink:href="archdischild-2013-305511.pdf"/>
      <kwd-group>
        <kwd>Virology</kwd>
        <kwd>Immunisation</kwd>
        <kwd>Infectious Diseases</kwd>
        <kwd>Respiratory</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>special-feature</meta-name>
          <meta-value>unlocked</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <p>From 2013 an annual nasal live-attenuated influenza vaccine (LAIV&#x2014;Fluenz) is available for all children in the UK aged 2 and 3&#x2005;years and other &#x2018;at-risk&#x2019; children, as part of the National Health Service (NHS) childhood vaccination programme.<xref rid="archdischild-2013-305511_R1" ref-type="bibr">1</xref>
<xref rid="archdischild-2013-305511_R2" ref-type="bibr">2</xref> The vaccine contains reassortant influenza viruses; two influenza A viruses (H1N1 and H3N2) and one influenza B virus,<xref rid="archdischild-2013-305511_R3" ref-type="bibr">3</xref> and has previously been used in children in the USA.</p>
    <p>A 2-year-old child presented with respiratory symptoms. PCR assay of nasopharyngeal swab was strongly positive for Rhinovirus (Cycle Threshold, CT 21) and weakly positive for Influenza B (CT 37.6). Further questioning revealed that the child had received the intranasal influenza vaccine 10&#x2005;days previously. Due to the difference in CT values and detection of an alternative virus (Rhinovirus), a diagnosis of Rhinovirus bronchiolitis was made and the weak Influenza B positivity was attributed to the intranasal vaccine.</p>
    <p>Immunocompetent children vaccinated with LAIV can shed vaccine viruses for up to 3&#x2005;weeks (mean duration: 7.6&#x2005;days); maximal shedding occurs within 2&#x2005;days of vaccination. Shedding is in lower amounts than with wild-type influenza viruses. Rarely, shed vaccine viruses can be transmitted from vaccine recipients to unvaccinated persons; however, serious illness has not been reported.<xref rid="archdischild-2013-305511_R4" ref-type="bibr">4</xref>
</p>
    <p>Both wild-type and live-attenuated vaccine virus strains are detected by laboratory respiratory PCR assay. Wild-type and vaccine virus strains could be distinguished by genome sequencing; however, the low copy number of shed vaccine virus precludes this approach. In this case, a clinical decision must be made as to whether the influenza virus is the cause of disease or a consequence of vaccination. This will influence decisions about treating with antivirals.</p>
    <p>As LAIV is introduced into UK clinical practice, this is a useful reminder to take care in interpreting respiratory PCR results in recently vaccinated children, highlighting the need for a precise vaccination history.</p>
  </body>
  <back>
    <fn-group>
      <fn>
        <p><bold>Contributors:</bold> SL and CA prepared the manuscript and TH reviewed.</p>
      </fn>
      <fn>
        <p><bold>Competing interests:</bold> None.</p>
      </fn>
      <fn>
        <p><bold>Provenance and peer review:</bold> Not commissioned; internally peer reviewed.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="archdischild-2013-305511_R1">
        <label>1</label>
        <mixed-citation publication-type="other">
<article-title>Immunisation against infectious disease</article-title>. <comment>PHE: September 2013. Chapter 19: Influenza. <ext-link ext-link-type="uri" xlink:href="https://www.gov.uk/government/publications/influenza-the-green-book-chapter-19">https://www.gov.uk/government/publications/influenza-the-green-book-chapter-19</ext-link> (accessed 28 Oct 2013)</comment>.</mixed-citation>
      </ref>
      <ref id="archdischild-2013-305511_R2">
        <label>2</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thors</surname><given-names>V</given-names></name><name><surname>Smith</surname><given-names>C</given-names></name><name><surname>Finn</surname><given-names>A</given-names></name></person-group>
<article-title>Should all children be immunised against influenza?</article-title>
<source>Arch Dis Child</source>
<year>2013</year>;<volume>98</volume>:<fpage>846</fpage>&#x2013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">23908190</pub-id></mixed-citation>
      </ref>
      <ref id="archdischild-2013-305511_R3">
        <label>3</label>
        <mixed-citation publication-type="other">
<collab>Fluenz Summary of Product Characteristics</collab>. <comment>August</comment>
<year>2013</year>
<comment><ext-link ext-link-type="uri" xlink:href="http://www.medicines.org.uk/emc/medicine/25084#COMPOSITION">http://www.medicines.org.uk/emc/medicine/25084#COMPOSITION</ext-link> (accessed 28 Oct 2013)</comment>.</mixed-citation>
      </ref>
      <ref id="archdischild-2013-305511_R4">
        <label>4</label>
        <mixed-citation publication-type="journal">
<collab>Influenza Division, National Center for Immunization and Respiratory Diseases, CDC</collab>. <article-title>Prevention and control of seasonal influenza with vaccines</article-title>. <source>MMWR Recomm Rep</source>
<year>2013</year>;<volume>62</volume>
<issue>(RR-07)</issue>:<fpage>1</fpage>&#x2013;<lpage>43</lpage>. <comment><ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6207a1.htm">http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6207a1.htm</ext-link> (accessed 28 Oct 2013)</comment>.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
